Skip to content

Patient Education in NorthTrondelag Hospital Trust

Patient Education in NorthTrondelag Hospital Trust - Interventions, Effects and Patient Experience

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00326222
Enrollment
146
Registered
2006-05-16
Start date
2006-05-31
Completion date
2008-11-30
Last updated
2016-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Patient Education as a Topic, Self-Management Program, Health promotion, Self Efficacy, Quality of life

Brief summary

The purpose of this randomised open study is to examine the effect of self-management program for diabetes patients.

Detailed description

The primary aim in this study is HbA1c in addition to secondary aims like quality of life and coping.

Interventions

BEHAVIORALLifestyle counseling

Self-management group education

Sponsors

Helse Nord-Trøndelag HF
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with ICPC-2, code T89 - diabetes dependent on insulin and T90 diabetes not dependent on insulin

Exclusion criteria

* Diagnosed with ICPC-2, code T89 - diabetes mellitus juvenile and diabetes I * Attended self-management program previous 12 months

Design outcomes

Primary

MeasureTime frame
HbA1cBaseline, 6, and 12 mds
PAM - Patient activation measureBaseline, 6, and 12 mds

Secondary

MeasureTime frame
Hunt diabetesBaseline, 6, and 12 mds
WHO-DTSQBaseline, 6, and 12 mds
Knowledge of diabetesBaseline, 6, and 12 mds
HDL-cholesterolBaseline, 6, and 12 mds
Total cholesterolBaseline, 6, and 12 mds
SF36Baseline, 6, and 12 mds
Blood pressureBaseline, 6, and 12 mds
WeightBaseline, 6, and 12 mds
BMIBaseline, 6, and 12 mds
Cost/benefitBaseline, 6, and 12 mds
TriglycerideBaseline, 6, and 12 mds
CreatininBaseline, 6, and 12 mds
EQ 5D-VAS scaleBaseline, 6, and 12 mds

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026